ArticleClinical ophthalmology (Auckland, N.Z.)2013

Two-year outcomes of pro re nata ranibizumab monotherapy for exudative age-related macular degeneration in Japanese patients.

Akiko Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.